IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virtus Advisers, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 376 holdings | $24.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
C4 Therapeutics Inc(CCCC)COM STK12529R107$180.0K5,5890.7%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$183.0K20,4810.8%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$191.0K6,7260.8%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$193.0K3,1660.8%
Axsome Therapeutics Inc(AXSM)COM05464T104$202.0K5,3500.8%
Cytokinetics Inc(CYTK)COM NEW23282W605$202.0K4,4250.8%
Arvinas Inc(ARVN)COM04335A105$205.0K2,4940.8%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$227.0K10,9650.9%
Crescent Cap BDC Inc(CCAP)COM225655109$328.0K18,6531.3%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$340.0K2,0031.4%
Biontech SE(BNTX)SPONSORED ADS09075V102$346.0K1,3441.4%
Beigene LTD(ONC)SPONSORED ADR07725L102$362.0K1,3361.5%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$366.0K2,7221.5%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$377.0K16,1721.5%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$379.0K11,5411.6%
Biogen Inc(BIIB)COM09062X103$387.0K1,6121.6%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$396.0K4,4861.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$451.0K32,5421.8%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$472.0K20,6531.9%
Barrick Gold Corp(ABX)COM067901108$2.0M106,6598.3%
DTE Energy Co(DTE)COM233331107$2.1M17,2648.5%
Cousins Pptys Inc(CUZ)COM NEW222795502$2.1M52,4458.7%
DT Midstream Inc(DTM)COMMON STOCK23345M107$2.1M44,7278.8%
Cubesmart(CUBE)COM229663109$2.2M38,3218.9%
Crown Castle Intl Corp New(CCI)COM22822V101$2.2M10,4959.0%
Conocophillips(COP)COM20825C104$2.3M31,6059.3%
PreviousPage 8 of 8